Mr Manjit Mehat is a Consultant Ophthalmologist who specialises in cataract surgery; vitreoretinal surgery on conditions including macular holes, epiretinal membranes and retinal detachment surgery; and medical treatment of retinal conditions (medical retina), including macular degeneration, diabetic eye disease and vascular disorders of the retina. He is a registered specialist with the General Medical Council, a Fellow of the Royal College of Ophthalmologists and an honorary research associate at the Institute of Ophthalmology.
Mr Mehat studied medicine at the University of Leeds, qualifying with distinction. While in medical school, he won the Tomlinson Prize in Ophthalmology for aspiring ophthalmologists. He was also awarded the prestigious Centenary and Hardwick Prize and the Wellcome Trust Elective Prize for undertaking an eye research project in rural India.
He underwent his ophthalmic specialist training at Birmingham & Midland Eye Centre and the world-renowned Moorfields Eye Hospital in London. Upon completion of his training, he was awarded Fellowship of Royal College of Ophthalmologists.
In 2012, the Medical Research Council and Royal College of Ophthalmologists awarded Mr Mehat £250,000 to investigate the application of stem cell therapy for macular degeneration. He performed his research at the Institute of Ophthalmology in London and was awarded a PhD by University College London for its successful completion. He was subsequently appointed as a NIHR Clinical Lecturer in Ophthalmology at the University College London and Honorary fellow at Moorfields Eye Hospital in 2017. He has a particular interest in the application of novel gene and cell therapy to treat blindness.
Following this, he furthered his specialist interest in retinal conditions by training as a fellow at the Moorfields Eye Hospital, spending two years performing complex vitreoretinal surgery and cataract surgery.
He is a co-investigator in the world’s first gene therapy trial for an inherited retinopathy, published in the New England Journal of Medicine (2015) and more recently a lead author of Europe’s first stem cell transplantation trial in macular degeneration (Ophthalmology 2018).
He is currently an honorary research associate at the Institute of Ophthalmology and participates in clinical research trials on new treatments for medical retinal conditions such as macular degeneration. He has published and presented over 40 papers on clinical ophthalmology and basic science research at international meetings and in peer-reviewed journals.